| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/22/2012 | EP2419103A1 Use of multi-kinase inhibitors in the treatment of vascular hyperpermeability |
| 02/22/2012 | EP2419101A2 Method of treating disorders associated with protein kinase ck2 activity |
| 02/22/2012 | EP1995240B1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 02/22/2012 | EP1799268B1 Magnetic particles for therapy and diagnosis |
| 02/22/2012 | EP1534289B2 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
| 02/22/2012 | EP1509231B1 System for peritoneal dialysis comprising a reservoir of dialysis solution and a cartridge containing taurolidine powder |
| 02/22/2012 | CN102358751A Human fibrinogen-like protein 2 prothrombinase immunogenicity peptide and use thereof |
| 02/22/2012 | CN102357220A Traditional Chinese medicine composition for treating early-stage lower limb thrombotic deep phlebitis |
| 02/22/2012 | CN102357195A Medicinal composition for treating cardiovascular and cerebrovascular diseases, and preparation method and application thereof |
| 02/22/2012 | CN102357185A Traditional Chinese medicine for treating septicemia |
| 02/22/2012 | CN102357167A Chinese medicine for treating uterine bleeding |
| 02/22/2012 | CN102357163A Traditional Chinese medicine preparation for treating menstrual discomfort |
| 02/22/2012 | CN102357152A Chinese medicine composite for treating formation of cerebral thrombosis |
| 02/22/2012 | CN102357134A Medicine for preventing and treating Alzheimer disease and cerebral thrombosis and preparation method thereof |
| 02/22/2012 | CN102357115A Sugar-free compound wintercreeper mixture and production method thereof |
| 02/22/2012 | CN101381412B 聚合物/重组人促红素偶联物 Polymer / recombinant human erythropoietin conjugates |
| 02/22/2012 | CN101247794B 阿肽地尔的制剂 A peptide formulations Seoul |
| 02/21/2012 | US8119665 Aryl imidazoles and related compounds as C5a receptor modulators |
| 02/21/2012 | US8119597 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 02/21/2012 | US8119141 Cinnamomi and poria composition, method to prepare same and uses thereof |
| 02/21/2012 | CA2488372C Pyridazine derivatives which are phosphodiasterase iv inhibitors |
| 02/21/2012 | CA2439123C Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 02/21/2012 | CA2436323C Process for preparing clopidogrel |
| 02/21/2012 | CA2427080C Platelet aggregation inhibitor and supplement food effective for inhibiting platelet aggregation |
| 02/21/2012 | CA2406626C Hemostatically active vwf-containing preparation and process for the preparation thereof |
| 02/21/2012 | CA2349760C Bovine cells expressing adeno virus essential functions for propagation of recombinant adenoviral vectors |
| 02/16/2012 | WO2012021088A1 A novel conjugate of granulocyte colony-stimulating factor (g-csf) with polyethylene glycol |
| 02/16/2012 | WO2012020218A1 Compositions and methods for inducing platelet aggregation |
| 02/16/2012 | US20120041056 Nucleic acids specifically binding with human factor vii/viia and uses thereof |
| 02/16/2012 | US20120041031 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists |
| 02/16/2012 | US20120041006 Compositions for Raising Uric Acid Levels and Methods of Using the Same |
| 02/16/2012 | US20120040987 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors |
| 02/16/2012 | US20120040974 Mif modulators |
| 02/16/2012 | US20120040964 N-substituted piperidines and their use as pharmaceuticals |
| 02/16/2012 | US20120040961 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders |
| 02/16/2012 | US20120040956 Inhibitors of hif-1 protein accumulation |
| 02/16/2012 | US20120040951 Heteroaryl compounds useful as raf kinase inhibitors |
| 02/16/2012 | US20120040905 Means for purifying a coagulation protein, and methods for implementing same |
| 02/16/2012 | US20120040902 Method of treating dyspnea associated with acute heart failure |
| 02/16/2012 | US20120040886 Analogues of Neuropeptide Y Having Proline Substitution At Position 34 |
| 02/16/2012 | US20120040024 Methods and compositions for enhancing survivability of cells, tissues, organs and organisms |
| 02/16/2012 | US20120040012 Therapeutic stem cell nutrient composition and uses thereof |
| 02/16/2012 | US20120039918 Composition for Enhancing Immunity Containing Plant Stem Cell Line Derived from Cambium of Panax Ginseng Including Wild Ginseng or Ginseng as an Active Ingredient |
| 02/16/2012 | US20120039883 Detection and diagnosis of inflammatory disorders |
| 02/16/2012 | US20120039864 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof |
| 02/16/2012 | US20120039863 Recombinant factor x with no glycosylation and method for preparing the same |
| 02/16/2012 | CA2807051A1 Besylate salt of a btk inhibitor |
| 02/15/2012 | EP2418200A1 Phthalimide derivatives of non-steroidal anti-inflammatory compounds and/or tnf- modulators, method for producing same, pharmaceutical compositions containing same and uses thereof for the treatment of inflammatory diseases |
| 02/15/2012 | EP2417131A1 Isoxazol-3(2h)-one analogs as therapeutic agents |
| 02/15/2012 | EP2416799A2 Par-1 activation by metalloproteinase-1 (mmp-1) |
| 02/15/2012 | EP2416790A1 Spray-dried blood products and methods of making same |
| 02/15/2012 | EP2288606B1 New co-crystal compound of rivaroxaban and malonic acid |
| 02/15/2012 | EP2170831B1 Benzazepine derivatives useful as vasopressin antagonists |
| 02/15/2012 | EP1771441B8 Novel carboxamides for use as xa inhibitors |
| 02/15/2012 | EP1581239B1 Early use of an extract of red vine leaves |
| 02/15/2012 | CN102355903A A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment |
| 02/15/2012 | CN102351962A Preparation method of chitosan glycine anticoagulation derivative |
| 02/15/2012 | CN102351948A Antithrombotic medicine RWR for specifically identifying platelet alpha<IIb>beta3 |
| 02/15/2012 | CN102351918A Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture |
| 02/15/2012 | CN102351880A Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors |
| 02/15/2012 | CN102351878A Isoxazole derivatives as well as preparation method and application thereof |
| 02/15/2012 | CN102351877A Thiophene derivative, its preparation method and its application |
| 02/15/2012 | CN102351874A New erigeroster compound with medicinal activity |
| 02/15/2012 | CN102351791A Cyanoisoquinoline compounds capable of making hypoxia inducible factor (HIF) stable |
| 02/15/2012 | CN102351705A Propylgallate compound and pharmaceutical composition thereof |
| 02/15/2012 | CN102349978A Application of hematogenesis pills in preparation of drug for preventing cell trauma caused by low-dose ionizing radiation |
| 02/15/2012 | CN102349965A Traditional Chinese medicine for treating dysfunctional uterine bleeding |
| 02/15/2012 | CN102349963A Health care product for preventing microthrombus from forming and preparation method thereof |
| 02/15/2012 | CN102349940A Process for preparing thermopsis lanceolate total alkaloids and several high-purity medicinal substances |
| 02/15/2012 | CN102349937A Preparation method of ixeris sonchifolia hance extractive |
| 02/15/2012 | CN102349933A Hemostatic refrigerant complex and preparation method thereof |
| 02/15/2012 | CN102349918A Composition of a prescription for nourishing blood, enriching blood and invigorating blood circulation and preparation of preparation of the prescription |
| 02/15/2012 | CN102349911A New application of Youtibi and derivatives of Youtibi |
| 02/15/2012 | CN102349901A Application of pirfenidone in preparation of medicaments for controlling proliferative diseases after ophthalmologic operation and eye drops thereof |
| 02/15/2012 | CN102349897A Meropenem sodium/tazobactam sodium medicinal composition |
| 02/15/2012 | CN102349896A Pharmaceutical composition of imipenem, cilastatin and sulbactam |
| 02/15/2012 | CN102349893A Edaravone pharmaceutical composition |
| 02/15/2012 | CN102133188B 一种西洛他唑脂质体固体制剂 One kind of cilostazol solid preparation of liposomes |
| 02/15/2012 | CN102119973B 一种栀子渗漉液质量控制方法 One kind of gardenia percolate quality control methods |
| 02/15/2012 | CN101843889B 一种治疗淋巴水肿和静脉水肿的药物及其应用 A lymphedema and venous edema drug therapy and its application |
| 02/15/2012 | CN101703614B 治疗功能失调性子宫出血的中药汤剂 Treatment of dysfunctional uterine bleeding decoction |
| 02/14/2012 | US8114970 Synthetic heparin monosaccharides |
| 02/14/2012 | US8114840 Medicament containing activated antithrombin III |
| 02/14/2012 | US8114648 immunizing a subject with a sufficient amount of a translated polypeptide to produce antibody; containing a phenylalanine or tyrosine derivative analoges |
| 02/14/2012 | CA2522179C Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles |
| 02/09/2012 | WO2012017932A1 Process for preparing compound by novel sandmeyer-like reaction using nitroxide radical compound as reaction catalyst |
| 02/09/2012 | WO2012017020A1 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein |
| 02/09/2012 | WO2012016930A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 02/09/2012 | WO2012016408A1 Pharmaceutical composition for treating hemorrhage caused by blood clotting disorder and use thereof |
| 02/09/2012 | US20120035270 Paediatric solutions comprising a beta-blocker |
| 02/09/2012 | US20120035259 Controlled Release of Nitric Oxide And Drugs From Functionalized Macromers And Oligomers |
| 02/09/2012 | US20120035257 Histone Deacetylase Inhibitors |
| 02/09/2012 | US20120035217 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 02/09/2012 | US20120035208 Pyrazolopyridine pi3k inhibitor compounds and methods of use |
| 02/09/2012 | US20120035179 Modulators of atp-binding cassette transporters |
| 02/09/2012 | US20120035154 Modulators of Cellular Adhesion |
| 02/09/2012 | US20120035140 Carbamoylphosphonates as inhibitors and uses thereof |
| 02/09/2012 | US20120035129 Hydrogel tissue adhesive having reduced degradation time |
| 02/09/2012 | US20120035110 METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE |
| 02/09/2012 | US20120035094 F11 receptor (f11r) antagonists as therapeutic agents |